Australia · Healthcare · AUD (Thousands) · Annual
Reported figures and Equlion model projections for the next 4 years.
Amounts in AUD (thousands); stock price per share. Values that are missing or fail Equlion's automated data-quality checks are shown as “-”. Projections are model estimates, not investment advice.
Want the full financial forecast report for UNIVERSAL BIOSENSORS INC.? It covers the balance sheet, income statement, cash flow and Equlion model projections.
| Key metrics | Actual | Forecast | |||
|---|---|---|---|---|---|
| Metric | 2025 | 2026 | 2027 | 2028 | 2029 |
| ROE | -81.97% | -9.45% | -12.41% | -14.38% | -18.17% |
|---|---|---|---|---|---|
| ROA | -55.11% | -5.89% | -6.56% | -6.31% | -6.62% |
| Gross Margin | 63.7% | 63.84% | 63.04% | 63.23% | 62.37% |
| Net Margin | -226.65% | -20.11% | -24.49% | -23.5% | -25.79% |
| Total Assets | A$25,840.76K | A$27,355.34K | A$28,942.06K | A$30,391.02K | A$30,391.02K |
| Net Income | -A$14,239.74K | -A$1,567.57K | -A$1,846.68K | -A$1,872.33K | -A$2,012.74K |